Skip to main content
. 2020 Jul 15;12:5831–5843. doi: 10.2147/CMAR.S257692

Table 1.

PD-L1 Expression (via Immunohistochemistry) and Clinical Characteristics of 118 Patients with Cervical Squamous Cell Carcinoma

Clinical or Pathologic Features Total No. PD-L1 Expression in Tumor Cells PD-L1 Expression in Stroma
Positive Negative p value Positive Negative p value
All cases 118a 69(58.5) 49(41.5) - 51(43.2) 67(56.8) -
Age at diagnosis 0.61 0.068
 < 35 years old 20 11(55.0) 9(45.0) 9(45.0) 11(55.0)
 35–55 years old 78 48(61.5) 30(38.5) 38(48.7) 40(51.3)
 >55 years old 20 10(50.0) 10(50.0) 4(20.0) 16(80.0)
Ethnicity 0.37 0.80
 Uygur 63 35(55.6) 28(44.4) 27(42.9) 36(57.1)
 Han 48 28(58.3) 20(41.7) 20(41.7) 28(58.3)
 Other minorities 7 6(85.7) 1(14.3) 4(57.1) 3(42.9)
Childbearing history 0.008 0.067
 0–2 times 60 28(46.7) 32(53.3) 21(35.0) 39(65.0)
 ≥ 3 times 58 41(70.7) 17(29.3) 30(51.7) 28(41.3)
Abortion history 0.001 0.66
 Yes 69 49(71.0) 20(29.0) 31(44.9) 38(55.1)
 No 49 20(40.8) 29(59.2) 20(40.8) 29(59.2)
HPV status 0.17 0.22
 HPV 16 44 24(54.5) 20(45.4) 20(45.5) 24(54.5)
 HVP18 35 22(62.9) 13(37.1) 18(51.4) 17(48.6)
 Other 24 11(45.8) 13(54.2) 10(41.7) 14(58.3)
 Negative 15 12(80.0) 3(20.0) 3(20.0) 12(80.0)
Tumor size 0.57 0.31
 ≤ 4 cm 47 26(55.3) 21(44.7) 23(48.9) 24(51.1)
 > 4 cm 71 43(60.6) 28(39.4) 28(39.4) 43(60.6)
Differentiation 0.20 0.87
 Low 66 42(63.6) 24(36.4) 31(47.0) 35(53.0)
 Middle/High 52 27(51.9) 25(48.1) 30(57.7) 32(61.5)
FIGO stage 0.95 0.14
 IA ~ IIA2 51 30(58.8) 21(41.2) 26(51.0) 25(49.0)
 ≥ IIB 67 39(58.2) 28(41.8) 25(37.3) 42(62.7)
Lymph node metastases 0.056 0.085
 Yes 30 22(73.3) 8(26.7) 17(56.7) 13(43.3)
 No 88 47(53.4) 41(46.6) 34(38.6) 54(61.4)

Notes: Data were shown as number of cases (%). aTwo samples could not be evaluated for PD-L1 owing to sample conditions.